$ME
23andMe Holding Co.

2023 Q4 Form 10-Q Financial Statement

#000180459124000025 Filed on February 07, 2024

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q1
Revenue $44.75M $92.38M
YoY Change -33.15% -8.14%
Cost Of Revenue $24.81M $52.40M
YoY Change -31.44% -2.07%
Gross Profit $19.94M $39.98M
YoY Change -35.17% -15.03%
Gross Profit Margin 44.55% 43.28%
Selling, General & Admin $59.13M $48.54M
YoY Change -16.23% -26.67%
% of Gross Profit 296.59% 121.4%
Research & Development $41.72M $60.72M
YoY Change -27.15% 20.66%
% of Gross Profit 209.27% 151.87%
Depreciation & Amortization $2.900M $8.366M
YoY Change -21.62% -7.68%
% of Gross Profit 14.55% 20.92%
Operating Expenses $301.1M $109.3M
YoY Change 135.54% -6.23%
Operating Profit -$281.2M -$69.27M
YoY Change 189.61% -0.26%
Interest Expense $3.230M $4.369M
YoY Change -12.01% 6726.56%
% of Operating Profit
Other Income/Expense, Net $23.00K $174.0K
YoY Change -97.31% -242.62%
Pretax Income -$278.0M -$64.73M
YoY Change 200.25% -6.88%
Income Tax $19.00K -$633.0K
% Of Pretax Income
Net Earnings -$278.0M -$64.10M
YoY Change 202.28% -7.83%
Net Earnings / Revenue -621.22% -69.39%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.58 -$0.14
COMMON SHARES
Basic Shares Outstanding 480.8M shares
Diluted Shares Outstanding 480.8M shares

Balance Sheet

Concept 2023 Q4 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $242.4M $386.8M
YoY Change -43.99% -30.07%
Cash & Equivalents $242.4M $386.8M
Short-Term Investments
Other Short-Term Assets $2.779M $26.00M
YoY Change -92.51% -24.5%
Inventory $15.67M $10.25M
Prepaid Expenses $11.45M $13.24M
Receivables $18.15M $1.897M
Other Receivables $5.867M $0.00
Total Short-Term Assets $310.0M $425.0M
YoY Change -39.06% -29.38%
LONG-TERM ASSETS
Property, Plant & Equipment $30.27M $38.61M
YoY Change -25.79% -22.55%
Goodwill $152.9M $351.7M
YoY Change -56.52% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.265M $3.021M
YoY Change -31.41% 16.51%
Total Long-Term Assets $298.3M $517.6M
YoY Change -42.2% -5.94%
TOTAL ASSETS
Total Short-Term Assets $310.0M $425.0M
Total Long-Term Assets $298.3M $517.6M
Total Assets $608.2M $942.6M
YoY Change -40.64% -18.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.17M $12.92M
YoY Change -5.85% -65.93%
Accrued Expenses $42.12M $66.43M
YoY Change -38.98% 48.99%
Deferred Revenue $80.47M $62.52M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $144.1M $149.4M
YoY Change -27.97% -2.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.443M $1.480M
YoY Change -31.55% -68.15%
Total Long-Term Liabilities $1.443M $1.480M
YoY Change -31.55% -68.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $144.1M $149.4M
Total Long-Term Liabilities $1.443M $1.480M
Total Liabilities $231.0M $228.7M
YoY Change -15.58% -3.28%
SHAREHOLDERS EQUITY
Retained Earnings -$1.964B -$1.506B
YoY Change 36.19% 26.09%
Common Stock $2.341B $2.221B
YoY Change 6.74% 5.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $377.2M $713.9M
YoY Change
Total Liabilities & Shareholders Equity $608.2M $942.6M
YoY Change -40.64% -18.18%

Cashflow Statement

Concept 2023 Q4 2023 Q1
OPERATING ACTIVITIES
Net Income -$278.0M -$64.10M
YoY Change 202.28% -7.83%
Depreciation, Depletion And Amortization $2.900M $8.366M
YoY Change -21.62% -7.68%
Cash From Operating Activities -$12.06M -$44.96M
YoY Change -147.23% 27.71%
INVESTING ACTIVITIES
Capital Expenditures $2.016M $3.293M
YoY Change -34.2% -203.0%
Acquisitions
YoY Change
Other Investing Activities -$4.000K $5.000K
YoY Change 100.0%
Cash From Investing Activities -$2.010M -$3.288M
YoY Change -34.44% 2.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 104.0K 2.606M
YoY Change -1045.45% -52.81%
NET CHANGE
Cash From Operating Activities -12.06M -44.96M
Cash From Investing Activities -2.010M -3.288M
Cash From Financing Activities 104.0K 2.606M
Net Change In Cash -13.97M -45.64M
YoY Change -162.18% 38.82%
FREE CASH FLOW
Cash From Operating Activities -$12.06M -$44.96M
Capital Expenditures $2.016M $3.293M
Free Cash Flow -$14.08M -$48.25M
YoY Change -162.64% 50.76%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.45
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.02
CY2023Q4 us-gaap Goodwill
Goodwill
152944000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
351744000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2265000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3021000 usd
CY2023Q4 us-gaap Assets
Assets
608211000 usd
CY2023Q1 us-gaap Assets
Assets
942598000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
13166000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
12924000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
42124000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
66430000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
80468000 usd
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
62521000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
8381000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7541000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
144139000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
149416000 usd
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
15000000 usd
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
0 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
70441000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
77763000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1443000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1480000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
231023000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
228659000 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
48000 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
46000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2341394000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2220897000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-620000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1964254000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1506384000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
377188000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
713939000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
608211000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
942598000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
44747000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
66940000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
155610000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
207112000 usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
24811000 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
36189000 usd
us-gaap Cost Of Revenue
CostOfRevenue
83265000 usd
us-gaap Cost Of Revenue
CostOfRevenue
112598000 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
19936000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
30751000 usd
us-gaap Gross Profit
GrossProfit
72345000 usd
us-gaap Gross Profit
GrossProfit
94514000 usd
CY2023Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41720000 usd
CY2022Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
57270000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
158637000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
161877000 usd
CY2023Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
27683000 usd
CY2022Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
39879000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
68669000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
98148000 usd
CY2023Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
31446000 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30702000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
107476000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
89226000 usd
CY2023Q4 us-gaap Restructuring Charges
RestructuringCharges
1497000 usd
CY2022Q4 us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring Charges
RestructuringCharges
8368000 usd
us-gaap Restructuring Charges
RestructuringCharges
0 usd
CY2023Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
198800000 usd
CY2022Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
198800000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
301146000 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
127851000 usd
us-gaap Operating Expenses
OperatingExpenses
541950000 usd
us-gaap Operating Expenses
OperatingExpenses
349251000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-281210000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-97100000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-469605000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-254737000 usd
CY2023Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3230000 usd
CY2022Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3671000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
11289000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5307000 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
23000 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
855000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
501000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-267000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-277957000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-92574000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-457815000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-249697000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-613000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2139000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-277976000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-91961000 usd
us-gaap Net Income Loss
NetIncomeLoss
-457870000 usd
us-gaap Net Income Loss
NetIncomeLoss
-247558000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
0 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1943000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
620000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-277976000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-93904000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.58
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.97
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.97
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-0.55
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.55
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
472683220 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
472683220 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
449949829 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
449949829 shares
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
85000 usd
CY2023Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
121000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
47915000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-334000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-104624000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
675490000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
388000 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
22000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1411000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
22198000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
954000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-75270000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
625251000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
217000 usd
CY2023Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
15000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
29711000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-277976000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
377188000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
915656000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1533000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25915000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
624000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-89532000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
854196000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2498000 usd
CY2022Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
86000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3238000 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
24710000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
829000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-66065000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
819320000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
49000 usd
CY2022Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
58000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
25585000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1943000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-91961000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
750992000 usd
us-gaap Profit Loss
ProfitLoss
-457870000 usd
us-gaap Profit Loss
ProfitLoss
-247558000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
19171000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
24918000 usd
me Amortization And Impairment Of Internal Use Software
AmortizationAndImpairmentOfInternalUseSoftware
4374000 usd
me Amortization And Impairment Of Internal Use Software
AmortizationAndImpairmentOfInternalUseSoftware
3214000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
101198000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
93768000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
5000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-2026000 usd
us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
10126000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
198800000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Payments For Other Operating Activities
PaymentsForOtherOperatingActivities
504000 usd
us-gaap Payments For Other Operating Activities
PaymentsForOtherOperatingActivities
1000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
16257000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23428000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5420000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1172000 usd
me Increase Decrease In Deferred Cost Of Revenue
IncreaseDecreaseInDeferredCostOfRevenue
-6846000 usd
me Increase Decrease In Deferred Cost Of Revenue
IncreaseDecreaseInDeferredCostOfRevenue
-6636000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4490000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3772000 usd
me Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
5341000 usd
me Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
5570000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-755000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
711000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
669000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-23305000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-5906000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4265000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
32948000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
45996000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-6483000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-6708000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-36000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-2539000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-138535000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-120429000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
850000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2854000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
6000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Payments For Software
PaymentsForSoftware
6636000 usd
us-gaap Payments For Software
PaymentsForSoftware
5163000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7480000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-8017000 usd
me Proceeds From Exercise Of Stock Options
ProceedsFromExerciseOfStockOptions
687000 usd
me Proceeds From Exercise Of Stock Options
ProceedsFromExerciseOfStockOptions
3933000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3238000 usd
me Payments Of Deferred Offering Costs
PaymentsOfDeferredOfferingCosts
356000 usd
me Payments Of Deferred Offering Costs
PaymentsOfDeferredOfferingCosts
0 usd
me Payments For Taxes Related To Net Share Settlement Of Equity Awards
PaymentsForTaxesRelatedToNetShareSettlementOfEquityAwards
-158000 usd
me Payments For Taxes Related To Net Share Settlement Of Equity Awards
PaymentsForTaxesRelatedToNetShareSettlementOfEquityAwards
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1584000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7171000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
694000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-144431000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-120581000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
395222000 usd
CY2023Q4 us-gaap Revenues
Revenues
44747000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
561755000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
250791000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
441174000 usd
me Purchases Of Property And Equipment During The Period Included In Accounts Payable And Accrued Expenses
PurchasesOfPropertyAndEquipmentDuringThePeriodIncludedInAccountsPayableAndAccruedExpenses
213000 usd
me Purchases Of Property And Equipment During The Period Included In Accounts Payable And Accrued Expenses
PurchasesOfPropertyAndEquipmentDuringThePeriodIncludedInAccountsPayableAndAccruedExpenses
472000 usd
me Stock Based Compensation Capitalized For Internal Use Software Costs
StockBasedCompensationCapitalizedForInternalUseSoftwareCosts
2927000 usd
me Stock Based Compensation Capitalized For Internal Use Software Costs
StockBasedCompensationCapitalizedForInternalUseSoftwareCosts
2239000 usd
CY2023Q4 us-gaap Cash
Cash
242418000 usd
CY2022Q4 us-gaap Cash
Cash
432801000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1399000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1399000 usd
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
6974000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
6974000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
250791000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
441174000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 reportablesegment
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Fiscal Year</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company’s fiscal year ends on March 31. References to fiscal 2024 refer to the fiscal year ending March 31, 2024 and references to fiscal 2023 and fiscal 2022 refer to the fiscal years ended March 31, 2023 and March 31, 2022, respectively.</span></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and the related disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenue and expenses during the reporting period and the accompanying notes. Significant items subject to such estimates and assumptions include, but are not limited to the determination of standalone selling price for various performance obligations; the estimated expected benefit period for the rate and recognition pattern of breakage revenue for purchases where a saliva collection kit (“Kit”) is never returned for processing; the capitalization and estimated useful life of internal use software; the useful life of long-lived assets; fair value of intangible assets acquired in business combinations; the fair value of reporting units relative to the carrying amount of goodwill; the incremental borrowing rate for operating leases; stock-based compensation including the determination of the fair value of stock options, annual incentive bonuses payable in the form of restricted stock units (“RSUs”), as well as the Company’s common stock prior to the Closing Date of the Merger; and the valuation of deferred tax assets and uncertain tax positions. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that it believes are reasonable under the circumstances, including assumptions as to future events. Actual results could differ from these estimates, and such differences could be material to the condensed consolidated financial statements.</span></div>The Company is not aware of any specific event or circumstance that would require revisions to estimates, updates to judgments, or adjustments to the carrying value of assets or liabilities. These estimates may change, as new events occur and additional information is obtained, and will be recognized in the condensed consolidated financial statements as soon as they become known.
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Concentration of Credit Risk</span></div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Financial instruments that potentially subject the Company to a concentration of credit risk include cash, cash equivalents, and accounts receivable. The Company maintains a majority of its cash and cash equivalents with a single high-quality financial institution, the composition and maturities of which are regularly monitored by the Company. The Company’s revenue and accounts receivable are derived primarily from the United States. See Note 3, “</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Revenue,</span>” for additional information regarding geographical disaggregation of revenue. The Company grants credit to its customers in the normal course of business, performs credit evaluations of its significant customers on an as-needed basis, and does not require collateral. Concentrations of credit risk are limited as the Company’s trade receivables are primarily related to third parties, which collect its credit card receivables, and large multinational corporations. The Company regularly monitors the aging of accounts receivable balances.
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 reportablesegment
CY2023 me Proceeds From Reverse Recapitalization Transaction
ProceedsFromReverseRecapitalizationTransaction
309700000 usd
CY2023 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
250000000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
242400000 usd
CY2023Q4 us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
4400000 usd
CY2022Q4 us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
6800000 usd
us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
13400000 usd
us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
17800000 usd
CY2023Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
21600000 usd
CY2023Q4 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.28
CY2022Q4 us-gaap Revenues
Revenues
66940000 usd
us-gaap Revenues
Revenues
155610000 usd
us-gaap Revenues
Revenues
207112000 usd
CY2023Q4 me Adjusted Ebitda
AdjustedEBITDA
-47735000 usd
CY2022Q4 me Adjusted Ebitda
AdjustedEBITDA
-43272000 usd
me Adjusted Ebitda
AdjustedEBITDA
-142588000 usd
me Adjusted Ebitda
AdjustedEBITDA
-122642000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-277976000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-91961000 usd
us-gaap Net Income Loss
NetIncomeLoss
-457870000 usd
us-gaap Net Income Loss
NetIncomeLoss
-247558000 usd
CY2023Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3230000 usd
CY2022Q4 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
3671000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
11289000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
5307000 usd
CY2023Q4 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
23000 usd
CY2022Q4 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
855000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
501000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-267000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-613000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
55000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2139000 usd
CY2023Q4 me Depreciation And Amortization Net
DepreciationAndAmortizationNet
4921000 usd
CY2022Q4 me Depreciation And Amortization Net
DepreciationAndAmortizationNet
5257000 usd
me Depreciation And Amortization Net
DepreciationAndAmortizationNet
13873000 usd
me Depreciation And Amortization Net
DepreciationAndAmortizationNet
15512000 usd
CY2023Q4 me Amortization Of Acquired Intangible Assets
AmortizationOfAcquiredIntangibleAssets
2397000 usd
CY2022Q4 me Amortization Of Acquired Intangible Assets
AmortizationOfAcquiredIntangibleAssets
4265000 usd
me Amortization Of Acquired Intangible Assets
AmortizationOfAcquiredIntangibleAssets
9673000 usd
me Amortization Of Acquired Intangible Assets
AmortizationOfAcquiredIntangibleAssets
12847000 usd
CY2023Q4 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2022Q4 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
9968000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
9968000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
26357000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
34338000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
101198000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
93768000 usd
CY2023Q4 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 usd
CY2022Q4 us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 usd
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
2375000 usd
us-gaap Disposal Group Not Discontinued Operation Gain Loss On Disposal
DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
0 usd
CY2023Q4 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2022Q4 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
98000 usd
us-gaap Litigation Settlement Expense
LitigationSettlementExpense
0 usd
CY2023Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
198800000 usd
CY2022Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
198800000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q4 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
1000000 usd
CY2022Q4 us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
0 usd
us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
1000000 usd
us-gaap Loss Contingency Loss In Period
LossContingencyLossInPeriod
0 usd
CY2023Q4 me Adjusted Ebitda Net
AdjustedEBITDANet
-47735000 usd
CY2022Q4 me Adjusted Ebitda Net
AdjustedEBITDANet
-43272000 usd
me Adjusted Ebitda Net
AdjustedEBITDANet
-142588000 usd
me Adjusted Ebitda Net
AdjustedEBITDANet
-122642000 usd
me Fair Value Assets Level Two To Level One Transfers Amount
FairValueAssetsLevelTwoToLevelOneTransfersAmount
0 usd
CY2023 me Fair Value Assets Level Two To Level One Transfers Amount
FairValueAssetsLevelTwoToLevelOneTransfersAmount
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
198800000 usd
CY2023Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
198800000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11454000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13244000 usd
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
5867000 usd
CY2023Q1 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
3003000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2779000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
2977000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
20100000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
19224000 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
113260000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
113924000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
82990000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
75316000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30270000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38608000 usd
CY2023Q4 us-gaap Depreciation
Depreciation
2900000 usd
CY2022Q4 us-gaap Depreciation
Depreciation
3700000 usd
us-gaap Depreciation
Depreciation
8900000 usd
us-gaap Depreciation
Depreciation
11500000 usd
CY2023Q4 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 usd
CY2023Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
33349000 usd
CY2023Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
25180000 usd
CY2023Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
13522000 usd
CY2023Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
9519000 usd
CY2023Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
19827000 usd
CY2023Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
15661000 usd
CY2023Q4 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
2700000 usd
CY2022Q4 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
3500000 usd
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
9600000 usd
us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
7800000 usd
us-gaap Capitalized Computer Software Impairments1
CapitalizedComputerSoftwareImpairments1
500000 usd
CY2023Q4 me Amortization And Impairment Of Internal Use Software
AmortizationAndImpairmentOfInternalUseSoftware
1900000 usd
CY2022Q4 me Amortization And Impairment Of Internal Use Software And Stock Based Compensation
AmortizationAndImpairmentOfInternalUseSoftwareAndStockBasedCompensation
1100000 usd
me Amortization And Impairment Of Internal Use Software
AmortizationAndImpairmentOfInternalUseSoftware
4400000 usd
me Amortization And Impairment Of Internal Use Software And Stock Based Compensation
AmortizationAndImpairmentOfInternalUseSoftwareAndStockBasedCompensation
3600000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
67300000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
32066000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
35234000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
81500000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
24890000 usd
CY2023Q4 me Accrued Clinical Expenses
AccruedClinicalExpenses
10172000 usd
CY2023Q1 me Cumulative Impairment Charge
CumulativeImpairmentCharge
9968000 usd
CY2023Q1 me Cumulative Currency Translation
CumulativeCurrencyTranslation
1122000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
45520000 usd
CY2023Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2600000 usd
CY2022Q4 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4500000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10300000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
13400000 usd
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023Q4 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1980000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
7919000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
7919000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
6769000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5006000 usd
CY2023Q4 me Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
5641000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
35234000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
351744000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
198800000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
152944000 usd
CY2023Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
198800000 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
198800000 usd
CY2022Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q4 me Accrued Payables Current
AccruedPayablesCurrent
13090000 usd
CY2023Q1 me Accrued Payables Current
AccruedPayablesCurrent
17030000 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4601000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
5898000 usd
CY2023Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
7310000 usd
CY2023Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
8839000 usd
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
5740000 usd
CY2023Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
21600000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
5983369 shares
CY2023Q1 me Accrued Clinical Expenses
AccruedClinicalExpenses
11707000 usd
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1211000 usd
CY2023Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
1356000 usd
CY2023Q4 me Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
42124000 usd
CY2023Q1 me Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
66430000 usd
CY2023Q4 us-gaap Restructuring Charges
RestructuringCharges
1500000 usd
us-gaap Restructuring Charges
RestructuringCharges
8400000 usd
CY2023Q1 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
0 usd
us-gaap Restructuring Charges
RestructuringCharges
8368000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
8237000 usd
CY2023Q4 us-gaap Restructuring Reserve Current
RestructuringReserveCurrent
131000 usd
CY2023Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P7Y
CY2023Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
3400000 usd
CY2022Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
3300000 usd
CY2023Q4 us-gaap Variable Lease Cost
VariableLeaseCost
1500000 usd
CY2022Q4 us-gaap Variable Lease Cost
VariableLeaseCost
1400000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
10100000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
10100000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
4000000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
4000000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2560000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
15474000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
15946000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
15472000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
11666000 usd
CY2023Q4 me Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
41430000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
102548000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
23726000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
78822000 usd
CY2023Q4 us-gaap Purchase Obligation
PurchaseObligation
22200000 usd
us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
Each share of Class B common stock is convertible into one share of Class A common stock any time at the option of the holder and is automatically converted into one share of Class A common stock upon transfer
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
73646882 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
68050752 shares
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
217531118 shares
CY2023Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
163884802 shares
CY2023Q1 me Proceeds From Sales Agent Commission Percentage
ProceedsFromSalesAgentCommissionPercentage
0.030
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
68050752 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.20
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10621000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
13097016 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.25
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1517517 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
73646882 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
3.69
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y7M6D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1555000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
51938674 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.14
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y4M24D
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1555000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.87
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.42
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1200000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4400000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
37700000 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y4M24D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2022Q4 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0 shares
CY2023Q4 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
0 shares
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
1509536 shares
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
1130337 shares
CY2023Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26357000 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
34338000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
101198000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
93768000 usd
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2023Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
me Annual Compensation And Contribution Limits
AnnualCompensationAndContributionLimits
The Company matches the greater of 100% of the first 2% or 100% of the first $2,300 (subject to annual compensation and contribution limits) of employee contributions.
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.02
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
me Defined Contribution Plan Employer Matching Contribution Employees Gross Pay Amount
DefinedContributionPlanEmployerMatchingContributionEmployeesGrossPayAmount
2300000 usd
CY2023Q4 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
700000 usd
CY2022Q4 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
800000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2100000 usd
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1900000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-600000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2100000 usd
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001804591-24-000025-index-headers.html Edgar Link pending
0001804591-24-000025-index.html Edgar Link pending
0001804591-24-000025.txt Edgar Link pending
0001804591-24-000025-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
me-20231231.htm Edgar Link pending
me-20231231.xsd Edgar Link pending
me-20231231xex311.htm Edgar Link pending
me-20231231xex312.htm Edgar Link pending
me-20231231xex321.htm Edgar Link pending
me-20231231xex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
me-20231231_def.xml Edgar Link unprocessable
me-20231231_lab.xml Edgar Link unprocessable
me-20231231_pre.xml Edgar Link unprocessable
me-20231231_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
me-20231231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable